News

SCOUT (Sibutramine Cardiovascular OUTcome Trial) study, 6-year study requested by European regulatory authorities as a post-marketing commitment to evaluate cardiovascular safety in high-risk patients, is the basis for

Sanofi Pasteur said that the contract supported by the HHS Biomedical Advanced Research and Development Authority (BARDA) affords rapid response and production of a strain-matched pandemic influenza vaccine

The transaction is expected to make MorphoSys the sole source of Sloning’s Slonomics technology, which improves the assembly and quality of protein libraries. MorphoSys said that by integrating

Last year Almac had added carbonyl reductase, transaminase, hydrolase, nitrilase, and nitrile hydratase enzyme screening kits to its biocatalysis business. Almac said that the investment will be used

IRIS is a manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of personalized diagnostics testing services through

EPIC Bio will develop, manufacture and commercialise pandemic influenza vaccines and therapeutics. EPIC Bio plans to begin clinical manufacturing of a broad spectrum influenza vaccine candidate in 2011

Endo Pharma has filed lawsuit on 4 March 2010, following Watson’s filing of an abbreviated new drug application (ANDA) with the US Food and Drug Administration (FDA) for

Profil Institute said that its screening for eligible study participants in Orange County takes place at Fountain Valley Regional Hospital and Medical Center, in the northwest corner of

Govindarajan will oversee active pharmaceutical ingredients (APIs) Operations and CRAMS development business at Aurobindo. He will be reporting to the managing director of the company. Most recently, Govindarajan